The Journal of Clinical Medicine retracts the article “Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?” [1], cited above.
Following publication, concerns were brought to the attention of the publisher regarding potential redundancy with a previous publication [2] from the same authorship group.
Adhering to our complaint’s procedure, an investigation was conducted by the Editorial Office and the Editorial Board that confirmed a significant overlap between the two publications. As a result, the Editorial Office and Editorial Board consider this publication [1] to be redundant, and therefore have decided to retract it as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30) and in line with the Committee on Publication Ethics’ retraction guidelines (https://publicationethics.org/retraction-guidelines).
This retraction was approved by the Editor-in-Chief of the Journal of Clinical Medicine.
The authors did not provide a comment on this retraction decision.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.De Vecchis R., Cantatrione C., Mazzei D., Baldi C. RETRACTED: Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice? J. Clin. Med. 2016;5:86. doi: 10.3390/jcm5100086. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 2.De Vecchis R., Cantatrione C., Mazzei D. Vasopressin receptor antagonists in patients with chronic heart failure. Herz. 2017;42:492–497. doi: 10.1007/s00059-016-4482-9. [DOI] [PubMed] [Google Scholar]